You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

CEFDITOREN PIVOXIL - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for cefditoren pivoxil and what is the scope of patent protection?

Cefditoren pivoxil is the generic ingredient in one branded drug marketed by Vansen Pharma and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for cefditoren pivoxil.

Summary for CEFDITOREN PIVOXIL
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 5
Raw Ingredient (Bulk) Api Vendors: 105
Clinical Trials: 3
Patent Applications: 2,113
What excipients (inactive ingredients) are in CEFDITOREN PIVOXIL?CEFDITOREN PIVOXIL excipients list
DailyMed Link:CEFDITOREN PIVOXIL at DailyMed
Recent Clinical Trials for CEFDITOREN PIVOXIL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Meiji Pharma Spain S.A.Phase 4
Thammasat UniversityPhase 4
Tedec-Meiji Farma, S.A.Phase 3

See all CEFDITOREN PIVOXIL clinical trials

US Patents and Regulatory Information for CEFDITOREN PIVOXIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vansen Pharma SPECTRACEF cefditoren pivoxil TABLET;ORAL 021222-002 Jul 21, 2008 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Vansen Pharma SPECTRACEF cefditoren pivoxil TABLET;ORAL 021222-001 Aug 29, 2001 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for CEFDITOREN PIVOXIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Vansen Pharma SPECTRACEF cefditoren pivoxil TABLET;ORAL 021222-001 Aug 29, 2001 ⤷  Try a Trial ⤷  Try a Trial
Vansen Pharma SPECTRACEF cefditoren pivoxil TABLET;ORAL 021222-001 Aug 29, 2001 ⤷  Try a Trial ⤷  Try a Trial
Vansen Pharma SPECTRACEF cefditoren pivoxil TABLET;ORAL 021222-002 Jul 21, 2008 ⤷  Try a Trial ⤷  Try a Trial
Vansen Pharma SPECTRACEF cefditoren pivoxil TABLET;ORAL 021222-002 Jul 21, 2008 ⤷  Try a Trial ⤷  Try a Trial
Vansen Pharma SPECTRACEF cefditoren pivoxil TABLET;ORAL 021222-001 Aug 29, 2001 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.